Geno Drugs Private Limited - Company Profile

Q: Who are the current directors of Geno Drugs Private Limited?

The current directors of Geno Drugs Private Limited are Pramod Dilip Salgaocar, Chitra Pradip Mahatme.

It is a pharma private limited company based in Goa, Goa, India, established in 1993.

1993 Goa, Goa, India Struck Off

Last Updated: July 25, 2025

About Geno Drugs Private Limited

Geno Drugs Private Limited, a struck off private limited company, was established on 12 August 1993 in Goa, Goa, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232GA1993PTC001410. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pramod Dilip Salgaocar (Director), Chitra Pradip Mahatme (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at Sharvaninear Sport Complex Pedem Mapusa, Goa, Goa, 403507.

Company Details

CIN/LLPIN
U24232GA1993PTC001410
Registration Number
001410
Incorporation Date
12 August 1993
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Goa
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.50 M as on 25-07-2025
Paid Up Capital ₹ 0.10 M as on 25-07-2025
Company Age 32 Year, 6 Months
Last Filing with ROC 31 Mar 2010

Comprehensive Company Insights

Explore comprehensive insights into Geno Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Geno Drugs Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pramod Dilip Salgaocar	Director	12 Aug 1993	Current
Chitra Pradip Mahatme	Director	12 Aug 1993	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Geno Drugs.

Enhance accessibility to Geno Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Geno Drugs?

Unlock access to Geno Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Geno Drugs?

Unlock and access historical data on people associated with Geno Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Geno Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geno Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Geno Drugs

Recent Activity within the Organization

Annual General Meeting

Progress on Geno Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was documented.
30 Sep 2010
Balance Sheet

Geno Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Goa. was recorded as a recent event.
31 Mar 2010
Director Appointment

Pramod Dilip Salgaocar was appointed as a Director was appointed as a Director on 12 Aug 1993 & has been associated with this company since 32 years 6 months . was recorded as a recent event.
12 Aug 1993
Director Appointment

Chitra Pradip Mahatme was appointed as a Director was appointed as a Director on 12 Aug 1993 & has been associated with this company since 32 years 6 months . was recorded as a recent event.
12 Aug 1993
Company Incorporation

The activity Geno Drugs Private Limited was registered on 12 Aug 1993 with Roc Goa & aged 32 years 6 months as per MCA records. was completed.
12 Aug 1993

Explore recent activity and updates - View Recent Activity